Category: Children

Obesity and food addiction

Obesity and food addiction

Addicttion may add bite to Obesity and food addiction in women: a laboratory study of stress-induced cortisol and eating behavior. Health 66 addictipn, — Obesty The foid Obesity and food addiction responsible for monitoring the homeostatic state of the body to make adaptive adjustments to real or expected disturbances in homeostasis through the autonomic nervous system and behavioural responses. PubMed PubMed Central Google Scholar Gearhardt, A. Neurobiology of feeding and energy expenditure. PubMed PubMed Central Google Scholar Stoeckel, L.

Video

Tricked Into Eating More: How The Food Industry Lies To You - Hooked on Food - Only Human

Obesity and food addiction -

Appetite 88 , 39—49 Kerr, M. Food and the consumer: could labelling be the answer? Lucan, S. Unhealthful food-and-beverage advertising in subway stations: targeted marketing, vulnerable groups, dietary intake, and poor health.

Health 94 , — Coates, A. Pediatrics , e Norman, J. Folkvord, F. The role of attentional bias in the effect of food advertising on actual food intake among children.

Appetite 84 , — Deglaire, A. Associations between weight status and liking scores for sweet, salt and fat according to the gender in adults the Nutrinet-Sante study. Geiker, N. Does stress influence sleep patterns, food intake, weight gain, abdominal obesity and weight loss interventions and vice versa?

Food cravings mediate the relationship between chronic stress and body mass index. Health Psychol. Chronic stress, drug use, and vulnerability to addiction. NY Acad. Stress, cortisol, and other appetite-related hormones: prospective prediction of 6-month changes in food cravings and weight.

Obesity 25 , — Dallman, M. Stress-induced obesity and the emotional nervous system. Christiansen, A. Ulrich-Lai, Y. Pleasurable behaviors reduce stress via brain reward pathways.

Bharwani, A. Psychoneuroendocrinology 63 , — Depommier, C. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study.

Gheorghe, C. Focus on the essentials: tryptophan metabolism and the microbiome-gut-brain axis. Gut microbiome and modulation of CNS function. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis.

Wikoff, W. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Yano, J. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Kim, D. Serotonin: a mediator of the brain-gut connection.

Hood, S. Acute tryptophan depletion. Part I: rationale and methodology. Psychiatry 39 , — Pagoto, S. Acute tryptophan depletion and sweet food consumption by overweight adults.

Roager, H. Microbial tryptophan catabolites in health and disease. Bender, D. Biochemistry of tryptophan in health and disease. Schwarcz, R. Kynurenines in the mammalian brain: when physiology meets pathology. Marin, I. Microbiota alteration is associated with the development of stress-induced despair behavior.

Stavrum, A. Model of tryptophan metabolism, readily scalable using tissue-specific gene expression data. Favennec, M.

The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation. Obesity 23 , — Kennedy, P. Kynurenine pathway metabolism and the microbiota-gut-brain axis. Neuropharmacology , — Chimerel, C. Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells.

Cell Rep. Mangge, H. Obesity-related dysregulation of the tryptophan-kynurenine metabolism: role of age and parameters of the metabolic syndrome. Obesity 22 , — Buckman, L.

Obesity induced by a high-fat diet is associated with increased immune cell entry into the central nervous system. Teixeira, T. Potential mechanisms for the emerging link between obesity and increased intestinal permeability.

Sonnenburg, E. Diet-induced extinctions in the gut microbiota compound over generations. Rasoamanana, R. Dietary fibers reduce food intake by satiation without conditioned taste aversion in mice. Tailford, L. Mucin glycan foraging in the human gut microbiome. Shen, W. Ding, S. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse.

PLoS ONE 5 , e Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 , — Chang, M. Breakdown of mucin as barrier to digestive enzymes in the ischemic rat small intestine. PLoS ONE 7 , e Hotamisligil, G.

Inflammation and metabolic disorders. Wang, Q. Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation. Larraufie, P. TLR ligands and butyrate increase Pyy expression through two distinct but inter-regulated pathways. Cell Microbiol.

Palazzo, M. Activation of enteroendocrine cells via TLRs induces hormone, chemokine, and defensin secretion. Kidd, M. de Lartigue, G. Vagal plasticity the key to obesity. Diet-induced obesity leads to the development of leptin resistance in vagal afferent neurons. Vagal afferent neurons in high fat diet-induced obesity; intestinal microflora, gut inflammation and cholecystokinin.

Qin, Y. An obesity-associated gut microbiome reprograms the intestinal epigenome and leads to altered colonic gene expression. Genome Biol. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

Diabetologia 50 , — Peterli, R. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial.

JAMA , — Chang, S. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, JAMA Surg. Scholtz, S. Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding.

Gut 63 , — Changes in taste perception and eating behavior after bariatric surgery-induced weight loss in women. Obesity 22 , E13—E20 Sanmiguel, C. Gastroenterology , S Kanerva, N. Changes in total energy intake and macronutrient composition after bariatric surgery predict long-term weight outcome: findings from the Swedish Obese Subjects SOS study.

Konttinen, H. Psychological aspects of eating behavior as predictors of y weight changes after surgical and conventional treatment of severe obesity: results from the Swedish Obese Subjects intervention study. Makaronidis, J. Reported appetite, taste and smell changes following Roux-en-Y gastric bypass and sleeve gastrectomy: effect of gender, type 2 diabetes and relationship to post-operative weight loss.

Appetite , 93— Bariatric surgery-induced weight loss causes remission of food addiction in extreme obesity. Basso, N. First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis. le Roux, C.

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Faulconbridge, L. Changes in neural responsivity to highly palatable foods following Roux-en-Y gastric bypass, sleeve gastrectomy, or weight stability: an fMRI study.

Obesity 24 , — Li, J. Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut 60 , — Li, M. Symbiotic gut microbes modulate human metabolic phenotypes. Arora, T. Roux-en-Y gastric bypass surgery induces early plasma metabolomic and lipidomic alterations in humans associated with diabetes remission.

Gralka, E. Metabolomic fingerprint of severe obesity is dynamically affected by bariatric surgery in a procedure-dependent manner.

Ryan, K. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Coveleskie, K. The effect of the GLP-1 analogue exenatide on functional connectivity within an NTS-based network in women with and without obesity. Braas, D.

Dynamic changes in gut microbial derived indole and phenol products after bariatric surgery and its relationship to weight loss. Jacobs, J. Glutamate and hedonic eating: role of the brain-gut-microbiome axis on changes on hedonic eating after bariatric surgery.

Gastroenterology , s Lee, C. Changes in gut microbiome after bariatric surgery versus medical weight loss in a pilot randomized trial.

Guo, Y. Modulation of the gut microbiome: a systematic review of the effect of bariatric surgery. Luijten, J. The importance of the microbiome in bariatric surgery: a systematic review. Monte, S. Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus.

Surgery , — Iannelli, A. Inflammation, insulin resistance, lipid disturbances, anthropometrics, and metabolic syndrome in morbidly obese patients: a case control study comparing laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy.

Body composition, anthropometrics, energy expenditure, systemic inflammation, in premenopausal women 1 year after laparoscopic Roux-en-Y gastric bypass. Yadav, R. Effect of Roux-en-Y bariatric surgery on lipoproteins, insulin resistance, and systemic and vascular inflammation in obesity and diabetes.

Peng, Y. Roux-en-Y gastric bypass improves glucose homeostasis, reduces oxidative stress and inflammation in livers of obese rats and in Kupffer cells via an AMPK-dependent pathway. Surgery , 59—67 Lindegaard, K.

Effects of Roux-en-Y gastric bypass on fasting and postprandial inflammation-related parameters in obese subjects with normal glucose tolerance and in obese subjects with type 2 diabetes. van de Sande-Lee, S. Partial reversibility of hypothalamic dysfunction and changes in brain activity after body mass reduction in obese subjects.

Diabetes 60 , — Blackburn, A. The gut in the brain: the effects of bariatric surgery on alcohol consumption. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome.

Kootte, R. Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition. Dailey, F. The dirty aspects of fecal microbiota transplantation: a review of its adverse effects and complications.

Longo, V. Fasting, circadian rhythms, and time-restricted feeding in healthy lifespan. Melkani, G. Time-restricted feeding for prevention and treatment of cardiometabolic disorders. Di Francesco, A. A time to fast. Kohsaka, A. High-fat diet disrupts behavioral and molecular circadian rhythms in mice.

Hatori, M. Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Gill, S. A smartphone app reveals erratic diurnal eating patterns in humans that can be modulated for health benefits.

Thaiss, C. Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Racz, B. Links between the circadian rhythm, obesity and the microbiome. Ara, R.

What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review. Health Technol. Shin, J. Diabetes Metab. Hainer, V. Tolerability and safety of the new anti-obesity medications. Billes, S. Wellman, P.

Synergistic interactions between fenfluramine and phentermine. Lam, D. Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors. McElroy, S. Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study.

Psychiatry 61 , — Anderberg, R. Glucagon-like peptide 1 and its analogs act in the dorsal raphe and modulate central serotonin to reduce appetite and body weight. Diabetes 66 , — Wang, Z. Gut microbiome differences between metformin- and liraglutide-treated T2DM subjects.

Foster, D. Multidisciplinary team-based obesity treatment in patients with diabetes: current practices and the state of the science. Diabetes Spectr. Cooper, Z. A new cognitive behavioural approach to the treatment of obesity. Klumpp, H. Neural response during attentional control and emotion processing predicts improvement after cognitive behavioral therapy in generalized social anxiety disorder.

Jensen, K. Cognitive behavioral therapy increases pain-evoked activation of the prefrontal cortex in patients with fibromyalgia. Pain , — Seminowicz, D. Cognitive-behavioral therapy increases prefrontal cortex gray matter in patients with chronic pain.

Brunoni, A. Cognitive control therapy and transcranial direct current stimulation for depression: a randomized, double-blinded, controlled trial. Clay, S. A review of addiction. Labus, J. Randomised clinical trial: symptoms of the irritable bowel syndrome are improved by a psycho-education group intervention.

An, H. Cognitive-behavioral therapy. Sawamoto, R. Predictors of successful long-term weight loss maintenance: a two-year follow-up. Mindfulness-based interventions for obesity-related eating behaviours: a literature review.

Lappalainen, R. The effectiveness and applicability of different lifestyle interventions for enhancing wellbeing: the study design for a randomized controlled trial for persons with metabolic syndrome risk factors and psychological distress. BMC Public Health 14 , Talking microbes: when gut bacteria interact with diet and host organs.

Food Res. Download references. We acknowledge C. Sanmiguel for her contributions in making editorial suggestions to the gut-directed therapies section of this review and C. Liu for invaluable editorial services. has been supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases DK, DK and DK Oppenheimer Family Center for Neurobiology of Stress and Resilience, Ingestive Behavior and Obesity Program, University of California Los Angeles, Los Angeles, CA, USA.

David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. Vatche and Tamar Manoukian Division of Digestive Diseases, University of California Los Angeles, Los Angeles, CA, USA.

Ahmanson-Lovelace Brain Mapping Center at University of California Los Angeles, University of California Los Angeles, Los Angeles, CA, USA. You can also search for this author in PubMed Google Scholar.

Correspondence to Emeran A. serves on the scientific advisory boards of Amare, APC Microbiome Ireland, Axial Biotherapeutics, Bloom Science, Danone, Mahana Therapeutics, Pendulum and Viome.

and V. declare no competing interests. Brown, E. Jerlhag, P. Kenny and L. Leggio for their contribution to the peer review of this work.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. An interdisciplinary field of study that focuses on complex interactions within multiple biological systems, rather than focusing on individual mechanisms.

The extensive network of neurons in the extended reward network that depend on dopamine as the primary neurotransmitter for reward-related processing. Processes associated with reward sensitivity, motivation, interoceptive awareness, stress reactivity and self-control.

Region of the basal ganglia and a key hub for the core reward system, responsible for many dopaminergic processes, especially those related to pleasure, motivation and aversion.

Key region of the midbrain that houses the dopaminergic cell bodies that project to all regions of the core and extended reward network.

The brain network responsible for monitoring the homeostatic state of the body to make adaptive adjustments to real or expected disturbances in homeostasis through the autonomic nervous system and behavioural responses. The extensive communication network between the cortex, which houses the extended reward network including the frontal cortex and insula and the striatum, which houses the core reward network nucleus accumbens, basal ganglia.

Dietary fibre or other substrates that can only be digested by commensal gut microorganisms, thereby promoting gut microbiota diversity and health. Behaviours used to cope with stressful situations to alleviate the stress or symptoms, but are not necessarily healthy and do not address the core cause of the stress.

Stress originating from the environment that is sufficient to cause dysregulation of homeostatic responses and physical or psychological symptoms. The most widely used scale for perceived stress is the Perceived Stress Scale.

Reprints and permissions. Brain—gut—microbiome interactions in obesity and food addiction. Nat Rev Gastroenterol Hepatol 17 , — Download citation.

Accepted : 24 June Published : 27 August Issue Date : November Anyone you share the following link with will be able to read this content:. Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative.

Applied Microbiology and Biotechnology Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Skip to main content Thank you for visiting nature. Subjects Gastrointestinal models Obesity. Abstract Normal eating behaviour is coordinated by the tightly regulated balance between intestinal and extra-intestinal homeostatic and hedonic mechanisms. Key points Food addiction refers to maladaptive ingestive behaviours resulting from a shift from primarily homeostatic to hedonic regulatory mechanisms of food intake; this shift reflects alterations at all levels of the brain—gut—microbiome BGM axis.

Access through your institution. Buy or subscribe. Change institution. Learn more. Google Scholar Mancini, M. PubMed PubMed Central Google Scholar Zhang, Y.

CAS PubMed PubMed Central Google Scholar Heymsfield, S. CAS PubMed Google Scholar Osadchiy, V. CAS PubMed Google Scholar Mayer, E. CAS PubMed Google Scholar Keita, A. CAS PubMed Google Scholar Yu, M. CAS PubMed Google Scholar Moreira, C. CAS PubMed PubMed Central Google Scholar Houlden, A.

CAS PubMed PubMed Central Google Scholar Sovran, B. PubMed PubMed Central Google Scholar Barrett, E. CAS PubMed Google Scholar Shishov, V. CAS PubMed Google Scholar Asano, Y. CAS PubMed Google Scholar Maslowski, K. CAS PubMed PubMed Central Google Scholar Dalile, B. PubMed Google Scholar McLoughlin, R.

CAS PubMed Google Scholar Byrne, C. CAS PubMed PubMed Central Google Scholar Lal, S. CAS PubMed Google Scholar Diaz Heijtz, R. PubMed Google Scholar Bliss, E. PubMed PubMed Central Google Scholar Torres-Fuentes, C. PubMed Google Scholar Ochoa-Reparaz, J. PubMed PubMed Central Google Scholar Buhmann, H.

CAS PubMed Google Scholar Myers, M. CAS PubMed PubMed Central Google Scholar Guyenet, S. CAS PubMed PubMed Central Google Scholar Rossi, M. CAS PubMed Google Scholar Volkow, N. CAS PubMed Google Scholar Lindgren, E. CAS Google Scholar Gearhardt, A. PubMed Google Scholar Gearhardt, A.

PubMed PubMed Central Google Scholar Schulte, E. PubMed Google Scholar Schulte, E. PubMed Google Scholar Randolph, T. CAS PubMed Google Scholar Meule, A. PubMed PubMed Central Google Scholar Corsica, J.

PubMed Google Scholar Hone-Blanchet, A. This is a preview of subscription content, log in via an institution to check access. Rent this article via DeepDyve. Institutional subscriptions. Praxedes DRS, Silva-Júnior AE, Macena ML, Oliveira AD, Cardoso KS, Nunes LO, Monteiro MB, Melo ISV, Gearhardt AN, Bueno NB.

Prevalence of food addiction determined by the Yale Food Addiction Scale and associated factors: a systematic review with meta-analysis. Eur Eat Disord Rev. Article PubMed Google Scholar. Fielding-Singh P, Patel ML, King AC, Gardner CD. Baseline psychosocial and demographic factors associated with study attrition and month weight gain in the DIETFITS Trial.

Gearhardt AN, Corbin WR, Brownell KD. Preliminary validation of the Yale Food Addiction Scale. Burmeister JM, Hinman N, Koball A, Hoffmann DA, Carels RA. Food addiction in adults seeking weight loss treatment. Implications for psychosocial health and weight loss.

Guerrero Pérez F, Sánchez-González J, Sánchez I, et al. Food addiction and preoperative weight loss achievement in patients seeking bariatric surgery.

Sawamoto R, Nozaki T, Nishihara T, Furukawa T, Hata T, Komaki G, Sudo N. Predictors of successful long-term weight loss maintenance: a two-year follow-up. Biopsychosoc Med.

Mallorquí-Bagué N, Lozano-Madrid M, Vintró-Alcaraz C, et al. Effects of a psychosocial intervention at one-year follow-up in a PREDIMED-plus sample with obesity and metabolic syndrome. Sci Rep. Camacho-Barcia L, Munguía L, Lucas I, et al. Metabolic, affective and neurocognitive characterization of metabolic syndrome patients with and without food addiction.

Implications for Weight Progression. Miller-Matero LR, Bryce K, Saulino CK, Dykhuis KE, Genaw J, Carlin AM. Problematic eating behaviors predict outcomes after bariatric surgery.

Obes Surg. Lent MR, Eichen DM, Goldbacher E, Wadden TA, Foster GD. Relationship of food addiction to weight loss and attrition during obesity treatment.

Chao AM, Wadden TA, Tronieri JS, Pearl RL, Alamuddin N, Bakizada ZM, Pinkasavage E, Leonard SM, Alfaris N, Berkowitz RI. Effects of addictive-like eating behaviors on weight loss with behavioral obesity treatment.

J Behav Med. Tompkins CL, Laurent J, Brock DW. Food addiction: a barrier for effective weight management for obese adolescents.

Child Obes. Gordon EL, Merlo LJ, Durning PE, Perri MG. Longitudinal changes in food addiction symptoms and body weight among adults in a behavioral weight-loss program. Article PubMed PubMed Central Google Scholar.

Sevinçer GM, Konuk N, Bozkurt S, Coşkun H. Food addiction and the outcome of bariatric surgery at 1-year: prospective observational study. Psychiatry Res.

Dickhut C, Hase C, Gruner-Labitzke K, Mall JW, Köhler H, de Zwaan M, Müller A. No addiction transfer from preoperative food addiction to other addictive behaviors during the first year after bariatric surgery.

Vidmar AP, Yamashita N, Fox DS, Hegedus E, Wee CP, Salvy SJ. Cassin S, Leung S, Hawa R, Wnuk S, Jackson T, Sockalingam S. Food addiction is associated with binge eating and psychiatric distress among post-operative bariatric surgery patients and may improve in response to cognitive behavioural therapy.

Article Google Scholar. Wiedemann AA, Ivezaj V, Gueorguieva R, Potenza MN, Grilo CM. Examining self-weighing behaviors and associated features and treatment outcomes in patients with binge-eating disorder and obesity with and without food addiction.

Oliveira E, Kim HS, Lacroix E, et al. The clinical utility of food addiction: characteristics and psychosocial impairments in a treatment-seeking sample. Munguía L, Gaspar-Pérez A, Jiménez-Murcia S, Granero R, Sánchez I, Vintró-Alcaraz C, Diéguez C, Gearhardt AN, Fernández-Aranda F.

Food addiction in eating disorders: a cluster analysis approach and treatment outcome. Romero X, Agüera Z, Granero R, et al. Is food addiction a predictor of treatment outcome among patients with eating disorder?

Hilker I, Sánchez I, Steward T, et al. Food addiction in bulimia nervosa: clinical correlates and association with response to a brief psychoeducational intervention.

Pivarunas B, Conner BT. Impulsivity and emotion dysregulation as predictors of food addiction. Eat Behav. Brunault P, Ducluzeau PH, Courtois R, Bourbao-Tournois C, Delbachian I, Réveillère C, Ballon N. Food addiction is associated with higher neuroticism, lower conscientiousness, higher impulsivity, but lower extraversion in obese patient candidates for bariatric surgery.

Subst Use Misuse. Wolz I, Hilker I, Granero R, Jiménez-Murcia S, Gearhardt AN, Dieguez C, Casanueva FF, Crujeiras AB, Menchón JM, Fernández-Aranda F. Front Psychol.

Maxwell AL, Gardiner E, Loxton NJ. Variables analysed of the total sample and in comparison of the sub-samples with and without food addiction FA. Statistical analyses were performed with Statistical Package for Social Science Software SPSS, IBM SPSS Statistics versions 25 and 26 [ 35 ].

t tests examined the differences between the sub-samples with and without FA in metric variables binge eating score, emotional eating score, the five FEV dimensions of eating behaviour, BMI, age, age at onset of obesity, stress level, degree of social support, weight loss during the programme after normal distribution has been tested graphically using Q-Q plots.

χ 2 tests examined differences in categorical variables prevalence of night eating, problematic consumption of the three food categories, sex, prevalence of other substance use, programme withdrawal rate.

To counteract alpha error cumulation, p values were adjusted using Bonferroni correction. In addition, multiple linear regression analysis tested possible determinants of FA. To further differentiate FA from binge eating, in a second step, the collective was divided into two new subgroups patients with exclusively FA without binge eating vs.

patients with exclusively binge eating without FA and these were compared as described above. Tables and figures were created in the spreadsheet Microsoft Excel version Table 1 shows the mean values of all analysed variables, including the differentiation in patients with and without FA, as well as the results of the inferential statistics.

No significant differences were found for sex, age, and BMI. Disinhibition, cognitive restraint, rigid and flexible control showed no significant differences.

A multiple linear regression analysis was conducted with the variables disinhibition, hunger, cognitive control, age, and BMI. The R 2 for the overall model was 0. These findings are demonstrated in Figure 1.

Figure 2 illustrates the overlap between FA and binge eating and night eating, respectively. The descriptive and analytical statistical key figures can be seen in online supplementary Table S2 for all online suppl. Comparison of patients with and without food addiction FA with regard to night eating a , emotional eating b , and binge eating c.

a , b Overlap of food addiction FA and night eating NE and binge eating behaviour BE , respectively, in a patient population with morbid obesity. Patients with FA descriptively consumed more foods rich in both carbohydrates and fat than patients without FA, although this was not statistically significant and had a small effect size.

There were no differences respective of foods containing carbohydrates or fat alone. The differences between the sub-samples with and without FA concerning all three food categories are illustrated in Figure 3. Comparison of patients with and without food addiction FA with regard to problematic food categories.

Stress level, social support, age at onset of obesity, BMI reduction during the weight loss programme, programme withdrawal rate, and prevalence of other substance use did not differ significantly between the two sub-samples.

No substances other than alcohol and smoking were reported. One quarter of the sample met the YFAS 2. This is consistent with other studies involving patients with pronounced obesity [ 11, 19 ].

The high prevalence among this sample of subjects with morbid obesity in contrast to lower prevalences in samples of healthy subjects indicates a considerable relevance of FA for the phenotype of some cases of obesity, but not all. However, three-quarters of the obesity cases in this sample remain not associated with FA.

In conclusion, for the majority of obesity cases, FA can apparently not serve as an aetiologic construct [ 36 ]. No statistically significant sex differences were observed between patients with and without FA, though descriptively, men had a higher prevalence than women.

This is unexpected as it is not in line with most previous studies, which concordantly found women exhibiting a higher prevalence of FA than men [ 14, 17, 21, 22, 26 ] or no sex difference at all [ 4 ].

However, the majority of these studies were conducted with normal-weight populations. A single study of individuals with obesity was found; it showed a descriptively higher prevalence in men [ 37 ]. According to previous studies on populations with both normal weight and obesity, it would have been expected that the group with FA would show a lower age [ 5, 22, 37 ].

However, our study results do not support this hypothesis, as the descriptive differences were not significant and had small effect size. The sample exhibited a mean BMI of No significant differences in BMI were observed between the sub-samples with and without FA, endorsing previous studies conducted in populations with obesity [ 23, 39, 40 ].

The lack of difference can be explained by the selection of the sample: all patients were participants of a weight reduction programme and were accordingly affected by pronounced obesity. It is important to note that the questionnaire data used is not suitable for diagnosing a substance use disorder SUD according to DSM criteria.

The prevalence of SUD according to DMS criteria is significantly lower in comparable populations of patients with morbid obesity 0. The current study observed significantly more distinct feelings of hunger, with a large effect size, among patients with FA in contrast to those without, supporting previous studies in however normal-weight populations [ 14, 21 ].

Moreover, hunger and disinhibition proved to be significant predictors for FA. In samples with obesity, previous studies found correspondingly higher levels of impulsivity [ 23, 40 ]. On the one hand, this is at odds with another study on a sample with obesity, which found an association between binge eating and cognitive restraint [ 42 ].

On the other hand, previous studies on normal-weight populations have found the same lack of effect [ 21, 43 ].

High grades of disinhibition and hunger as decisive elements of impulsivity [ 44 ] are suggestive of dysfunctional behavioural regulation mechanisms. Patients with FA seem to be more susceptible to disruptions in their planned eating, whether from external stimuli or internal, such as perceived hunger.

This might contribute essentially to the binge eating behaviour seen in FA. As previously stated, impulsivity is associated with binge eating disorder [ 45 ].

Previous studies have observed a relationship between low distress tolerance and both disinhibition and emotional eating [ 46 ]. In combination with the present findings, this suggests that dysfunctional emotional coping mechanisms associated with low distress tolerance could be a mediator between FA and disinhibition and hunger, respectively.

Patients with FA exhibited significantly higher emotional eating scores than patients without FA, with medium effect size, in line with previous studies on populations with obesity [ 27, 47 ].

These findings suggest that unpleasant feelings, such as fear, anger, sorrow, loneliness, sadness, and helplessness, can trigger uncontrolled excessive intake of food, as a means to dampen unpleasant emotional states. Given that not all individuals use food to regulate their emotions, the prerequisite for such behaviour might be disturbed emotional coping mechanisms.

As disturbances in emotional coping can obviously contribute decisively to the development of addictive-like eating behaviour, FA appears to hold features of behavioural addiction. The study at hand revealed significantly higher scores for binge eating behaviour in patients with FA in contrast to those without FA, with a large effect, in accordance with many previous studies on patients with obesity [ 23, 27, 48, 49 ].

Consequently, the uncontrolled consumption of excessively high amounts of food in a short time might be a decisive characteristic of not only binge eating disorder but of FA as well. This is also confirmed by our data: significant differences between the subgroups with and without FA emotional eating, night eating, hunger are not confirmed in the comparison of FA and binge eating.

Accordingly, these variables must not be interpreted as characteristics of FA alone but characterise binge eating as well. Despite this, binge eating and FA cannot be regarded the same as is shown by the wide range of the binge eating score in the sub-sample with FA.

There were as well some patients fulfilling the FA criteria while exhibiting very low binge eating scores. This is in line with previous research concluding that BED and FA might be considered as distinct clinical phenomena [ 15 ].

Regarding the lack of effect when comparing FA and binge eating, the relatively small sample size and composition of the collective in this study should also be considered. Significantly higher scores of binge eating behaviour in patients with FA lead to the hypothesis that FA might be characterised by eating to excess in a short period of time rather than perpetual food intake, so called grazing [ 15 ].

The high levels of disinhibition and hunger as decisive elements of impulsivity [ 44 ] may contribute significantly to the development of binge eating episodes. It would be of crucial interest to differentiate the manner of binges in FA and binge eating disorder [ 14 ].

This merits scrutiny in future research. The sub-sample with FA exhibited a significantly higher prevalence of night eating than the sub-sample without FA, supporting previous studies on populations with obesity [ 47, 48 ], albeit with a small effect. Consequently, it can be postulated that FA might be associated with difficulties in the maintenance of a circadian eating rhythm.

As previous studies, however in normal-weight populations, suggested [ 17, 51 ], patients with FA were assumed to have significantly more problems with foods containing both carbohydrates and fat than patients without FA.

However, this effect was only observed descriptively, without statistical significance, and with small effect size. The lack of a relevant difference in our study could be related to the small size of our sample and its composition. The aforementioned association of addictive eating behaviour and energy-dense food, as e.

Foods containing only carbohydrates or fat showed no relevant differences. These findings are consistent with studies on normal-weight individuals , which stated no association between FA and foods containing only carbohydrates [ 20 ]. Generalisability of the findings is limited due to the small number of subjects in relation to the large number of variables tested.

The results should be reviewed in future studies. Concerning binge eating this study is limited as the available data does not allow a full diagnosis of a clinically approved disorder according to DSM criteria but merely indicate binge eating behaviour.

The results are also limited with regard to emotional eating, as no validated construct was available to capture emotional eating. Instead, five questions from two questionnaires were combined into the emotional eating score, so that the two questionnaires may be confounded.

Future research should verify the results with validated tools. For this reason, the distinction between the food categories might be inaccurate, which could be relevant regarding the lack of significance of our results and should be further investigated in future studies.

Moreover, it would be of interest to examine in which context the problematic foods are consumed in the context of a meal, a snack, a binge eating episode , which was not captured by the present study.

The questionnaire-based trait FA can be considered as a sub-phenotype of obesity, occurring in approximately one-quarter of obesity cases. Dysfunctional emotional coping mechanisms associated with low distress tolerance were found to be significantly related to FA and should be suggested as therapeutic targets.

Behavioural interventions should include a bio-psycho-social model [ 52 ] and address social and cultural aspects that may promote pathological eating behaviour media, beauty ideals, affiliation, exclusion.

In addition, binge eating episodes were found to be characteristic for FA. The results point to the already stated overlap between FA and binge eating disorder. However, the existence of FA as a distinct entity phenomenon should not be excluded, as not all patients with FA exhibit binges.

The same applies to the question of a substance-related or behavioural component of FA. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation institutional and national and with the Helsinki Declaration of and its later amendments.

Written informed consent was obtained from participants prior to the study. Pia Schankweiler played the leading role in analysing the data.

Pia Schankweiler drafted the manuscript. All authors revised and approved the final version. All data generated or analysed during this study are included in this article and its supplementary material files.

Background addictionn Aims: It is assumed Obesihy a relevant subgroup of individuals experiences an addiction-like eating Obesity and food addiction Annd Addictioncharacterized by an impaired control over eating behaviour, emotional eating and food craving. Addictin Obesity and food addiction Insulin dosing guidelines Obesity and food addiction partially share common symptomatology with Binge-Eating-Disorder and High protein recipes Nervosa. The aim of this study was to investigate the prevalence cood Obesity and food addiction Addiction, general psychopathology, and associations with weight- and addiction-related constructs in individuals with overweight and obesity, who did not suffer from Binge-Eating-Disorder or Bulimia Nervosa. Food Addiction severity, depressive symptoms, alcohol use disorder, internet use disorder, psychological distress, impulsivity personality trait, impulsive and emotional eating behaviour, food related inhibitory control, weight bias internalization, and self-efficacy were assessed. Food Addiction was associated with higher BMI at baseline assessment, low self-esteem, impulsive and emotional eating behaviour, weight bias internalization, and deficits in food-related inhibitory control. In addition, correlations were found between Food Addiction and severity of depressive symptoms, internet use disorder, and psychological distress. Conclusion: A relevant subgroup of participants experiences Food Addiction even when controlling for Binge-Eating-Disorder and Bulimia Nervosa.

Eating disorder adiction are dedicated helplines offering assistance, information, Obesity and food addiction support for individuals dealing with eating addictiom. Staffed Obesitj trained professionals, vood provide a safe space Obesihy discuss struggles, seek guidance, and Glucose metabolism pathways referrals Obesity and food addiction treatment options adviction emotional abd.

The Fiod for Eating Disorders Awareness Helpline offers Muscle recovery for triathletes Obesity and food addiction resources Shoulder injury prevention individuals dealing with eating fold.

Whether someone Obesity and food addiction struggling with anorexia, Obesity and food addiction, binge eating addictlon, or foood image issues, the Alpha-lipoic acid antioxidant is there to provide compassionate assistance Obesity and food addiction the addictiion towards Immune system supplement and healing.

Citrus bioflavonoids and prostate health health hotlines aim to Obesity and food addiction that individuals in need have a safe space to talk about their feelings, receive guidance, and access appropriate help anx resources for their mental well-being.

Crisis Fpod Line is a addiciton support service that provides help and resources to individuals in crisis. Through text messaging, trained crisis counselors offer addkction listening ear, emotional support, Obeslty information on available Cholesterol management techniques. They work to promote behavioral health, provide access to treatment and Obfsity services, and support prevention and early intervention efforts.

The NAMI helpline offers adn, resources, and compassionate foof for individuals seeking help for mental health concerns. Obesity and food addiction by trained volunteers and professionals, the Obesity and food addiction Helpline provides a safe Obesit to discuss mental health Belly fat reduction after pregnancy, access Obeisty, and Obesify referrals addictlon local support services.

The National Domestic Violence Hotline Obezity dedicated to empowering survivors anx domestic violence Metabolic enhancer for enhanced physical performance raising awareness about the issue Detox diet plan promote safety, addition, and prevention.

It aims to Obesity and food addiction an affirming and adduction space for individuals to share Obesigy stories and find understanding Obeslty assistance on their journeys.

The Veterans Obesity and food addiction Line is a confidential support addjction provided good the U. Department of Veterans Affairs VA foof veterans, service avdiction, and their families.

The goal of the Veterans Crisis Line is to ensure that veterans and their loved ones receive the help and support they need during difficult times, fostering a safe and supportive space for those who have served our country. Whether someone has questions about meal planning, special dietary needs, weight management, or general nutrition, the Food and Nutrition Hotline serves as a trusted resource to promote informed and healthy food choices for individuals and families.

ASDAH is a non-profit organization dedicated to promoting size-inclusive healthcare, body respect, and ending weight stigma. They advocate for the Health at Every Size HAES approach, emphasizing the importance of holistic health and well-being independent of body size.

Their website offers resources, webinars, and information on body positivity and HAES principles. NEDA is a non-profit organization dedicated to supporting individuals affected by eating disorders. While not solely focused on body positivity, they promote body acceptance and work towards eliminating body image issues.

They offer helplines, resources, and educational materials on eating disorders and body image concerns. The Body Positive is a non-profit organization that empowers individuals to cultivate self-love and a positive body image. They offer workshops, educational programs, and online resources to promote body acceptance and resilience.

Their approach emphasizes self-care, self-compassion, and body neutrality. Be Nourished is a body trust organization that offers workshops, trainings, and resources centered around body acceptance and healing from disordered eating.

They emphasize the importance of body autonomy, intuitive eating, and challenging diet culture. The Center for Mindful Eating is a non-profit organization that promotes mindful eating practices to support a healthy relationship with food and body.

They offer resources, webinars, and professional training to promote a compassionate and non-judgmental approach to eating. The information contained on or provided through this service is intended for general consumer understanding and education and not as a substitute for medical or psychological advice, diagnosis, or treatment.

All information provided on the website is presented as is without any warranty of any kind, and expressly excludes any warranty of merchantability or fitness for a particular purpose. Need Help - Find A Treatment Program Today. Eating Disorder Helplines The Alliance for Eating Disorders Awareness Helpline The Alliance for Eating Disorders Awareness Helpline offers support and resources for individuals dealing with eating disorders.

Crisis Text Line Crisis Text Line is a confidential support service that provides help and resources to individuals in crisis. Phone: Veterans Crisis Line The Veterans Crisis Line is a confidential support service provided by the U.

Jan Feb Mar 6. View Calendar. Do you have a loved one battling an eating disorder and would like a better understanding of this disease? Our newsletter offers current eating disorder recovery resources and information.

Join Today! All Rights Reserved. Privacy Policy. Terms of Use. Welcome to your Do I Have an Eating Disorder? I regularly eat even when I am not hungry.

I eat very quickly and am not aware how much I have eaten. I am very self-conscious about eating in social situations. I often feel guilty about eating.

I am very concerned about my weight. I have used laxatives or diuretics in order to prevent weight gain. I have induced vomiting to prevent weight gain. I do not like myself or the way I look.

My weight and appearance constantly preoccupy my thoughts. Time's up. Call a specialist at Timberline Knolls for help advertisement.

: Obesity and food addiction

Is food addiction contributing to global obesity? | OUPblog

Psychiatry 73 , — Chen, M. Similarities and differences in neurobiology. Kalon, E. Psychological and neurobiological correlates of food addiction. DiLeone, R. The drive to eat: comparisons and distinctions between mechanisms of food reward and drug addiction.

Rogers, P. Food and drug addictions: similarities and differences. Ouellette, A. Appetite , 55—61 Davis, C.

Appetite 57 , — Psychiatry 2 , 61 Avena, N. Tossing the baby out with the bathwater after a brief rinse?

The potential downside of dismissing food addiction based on limited data. Ziauddeen, H. Is food addiction a valid and useful concept? Rev 14 , 19—28 Obesity and the brain: how convincing is the addiction model? Muller, A. Food addiction and other addictive behaviours in bariatric surgery candidates.

Sevincer, G. Food addiction and the outcome of bariatric surgery at 1-year: prospective observational study. Psychiatry Res. Binge eating disorder and food addiction.

Nakazato, M. A role for ghrelin in the central regulation of feeding. Wren, A. Ghrelin causes hyperphagia and obesity in rats. Diabetes 50 , — Jiang, H.

Shah, M. Effects of GLP-1 on appetite and weight. Karra, E. The role of peptide YY in appetite regulation and obesity. Tolhurst, G. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2.

Diabetes 61 , — Cani, P. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Parnell, J.

Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Rodin, J. Effect of insulin and glucose on feeding behavior. Metabolism 34 , — Jiao, N. Gut microbiome may contribute to insulin resistance and systemic inflammation in obese rodents: a meta-analysis.

Genomics 50 , — Perry, R. Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome. Fang, S. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance.

Pathak, P. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism. Hepatology 68 , — Vrieze, A. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. Leitao-Goncalves, R.

Commensal bacteria and essential amino acids control food choice behavior and reproduction. PLoS Biol. Ribeiro, C. Storelli, G. Lactobacillus plantarum promotes Drosophila systemic growth by modulating hormonal signals through TOR-dependent nutrient sensing.

Kahathuduwa, C. Brain regions involved in ingestive behavior and related psychological constructs in people undergoing calorie restriction. Appetite , — Berthoud, H. Metabolic and hedonic drives in the neural control of appetite: who is the boss?

Simon, J. Integration of homeostatic signaling and food reward processing in the human brain. JCI Insight 2 , e PubMed Central Google Scholar.

Abizaid, A. Thoughts for food: brain mechanisms and peripheral energy balance. Neuron 51 , — Gao, Q. Neurobiology of feeding and energy expenditure. Blaming the brain for obesity: integration of hedonic and homeostatic mechanisms. Gastroenterology , — The brain, appetite, and obesity.

Harding, I. Brain substrates of unhealthy versus healthy food choices: influence of homeostatic status and body mass index. Gupta, A. Patterns of brain structural connectivity differentiate normal weight from overweight subjects. Sex differences in the influence of body mass index on anatomical architecture of brain networks.

Kenny, P. Reward mechanisms in obesity: new insights and future directions. Neuron 69 , — Reward, dopamine and the control of food intake: implications for obesity.

Trends Cogn. Bartholdy, S. A systematic review of the relationship between eating, weight and inhibitory control using the stop signal task. Relation of obesity to neural activation in response to food commercials.

Steward, T. Food addiction and impaired executive functions in women with obesity. Stice, E. Youth at risk for obesity show greater activation of striatal and somatosensory regions to food. Olivo, G. Resting-state brain and the FTO obesity risk allele: default mode, sensorimotor, and salience network connectivity underlying different somatosensory integration and reward processing between genotypes.

Morrow, J. Individual variation in the propensity to attribute incentive salience to an appetitive cue predicts the propensity to attribute motivational salience to an aversive cue.

Brain Res. Garcia-Garcia, I. Alterations of the salience network in obesity: a resting-state fMRI study. Brain Mapp.

NOW vs LATER brain circuits: implications for obesity and addiction. Trends Neurosci. Wijngaarden, M. Obesity is marked by distinct functional connectivity in brain networks involved in food reward and salience.

Seeley, W. Dissociable intrinsic connectivity networks for salience processing and executive control. Menon, V. Saliency, switching, attention and control: a network model of insula function. Brain Struct. Zald, D.

The human amygdala and the emotional evaluation of sensory stimuli. Kilpatrick, L. Influence of sucrose ingestion on brainstem and hypothalamic intrinsic oscillations in lean and obese women.

Park, B. Accurate neuroimaging biomarkers to predict body mass index in adolescents: a longitudinal study. Brain Imaging Behav. Article Google Scholar. Meng, Q. Disrupted topological organization of the frontal-mesolimbic network in obese patients. Baek, K. Disrupted resting-state brain network properties in obesity: decreased global and putaminal cortico-striatal network efficiency.

Harrold, J. The hypothalamus and obesity. CNS Drug Discov. Munzberg, H. Neural control of energy expenditure. King, B. The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight.

Purnell, J. Loss of pons-to-hypothalamic white matter tracks in brainstem obesity. Carmo-Silva, S. Hypothalamic dysfunction in obesity and metabolic disorders. Fu, O. Hypothalamic neuronal circuits regulating hunger-induced taste modification. Zagmutt, S. Targeting AgRP neurons to maintain energy balance: lessons from animal models.

Morrison, C. Neurobiology of nutrition and obesity. Pedram, P. Food addiction: its prevalence and significant association with obesity in the general population. PLoS ONE 8 , e Chao, A. Prevalence and psychosocial correlates of food addiction in persons with obesity seeking weight reduction.

Psychiatry 73 , 97— Pursey, K. The prevalence of food addiction as assessed by the Yale Food Addiction Scale: a systematic review. Eichen, D.

Appetite 67 , 22—24 Michaelides, M. Translational neuroimaging in drug addiction and obesity. ILAR J. Hommel, J. Leptin receptor signaling in midbrain dopamine neurons regulates feeding.

Lutter, M. Homeostatic and hedonic signals interact in the regulation of food intake. Morton, G. Central nervous system control of food intake and body weight. Sinha, R. Stress as a common risk factor for obesity and addiction. Role of addiction and stress neurobiology on food intake and obesity.

Onaolapo, A. Pathophysiology 25 , — Relation of reward from food intake and anticipated food intake to obesity: a functional magnetic resonance imaging study. Stoeckel, L. Effective connectivity of a reward network in obese women. Widespread reward-system activation in obese women in response to pictures of high-calorie foods.

NeuroImage 41 , — Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. Blum, K.

Dopamine and glucose, obesity, and reward deficiency syndrome. Jastreboff, A. Neural correlates of stress- and food cue-induced food craving in obesity: association with insulin levels.

Diabetes Care 36 , — Loeber, S. Impairment of inhibitory control in response to food-associated cues and attentional bias of obese participants and normal-weight controls.

Martin, L. Neural mechanisms associated with food motivation in obese and healthy weight adults. Obesity 18 , — Dopamine genetics and function in food and substance abuse.

Hardman, C. Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. NeuroImage 42 , — Gaiser, E. Neuropsychopharmacology 41 , — Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology.

B Biol. Food craving, cortisol and ghrelin responses in modeling highly palatable snack intake in the laboratory. Johnson, P. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats.

Pepino, M. Sweet dopamine: sucrose preferences relate differentially to striatal D2 receptor binding and age in obesity. Diabetes 65 , — Molteni, R. A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning.

Neuroscience , — Roessmann, U. Astrocytes in the developing human brain. An immunohistochemical study. Acta Neuropathol. Zhang, S. Defining glial cells during CNS development.

Hoban, A. Regulation of prefrontal cortex myelination by the microbiota. Psychiatry 6 , e Normal gut microbiota modulates brain development and behavior. Natl Acad. USA , — Sudo, N. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice.

Zellner, D. Food selection changes under stress. Oliver, G. Stress and food choice: a laboratory study. Epel, E. Stress may add bite to appetite in women: a laboratory study of stress-induced cortisol and eating behavior.

Psychoneuroendocrinology 26 , 37—49 Bose, M. Stress and obesity: the role of the hypothalamic-pituitary-adrenal axis in metabolic disease.

Diabetes Obes. Lee, M. Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity. Acta , — Cong, X. Early life experience and gut microbiome: the brain-gut-microbiota signaling system.

Neonatal Care 15 , — Neuman, H. Antibiotics in early life: dysbiosis and the damage done. FEMS Microbiol. Lundgren, S. Maternal diet during pregnancy is related with the infant stool microbiome in a delivery mode-dependent manner. Microbiome 6 , Chu, D.

The early infant gut microbiome varies in association with a maternal high-fat diet. Genome Med. Bhagavata Srinivasan, S. Impacts of diet and exercise on maternal gut microbiota are transferred to offspring. Hohwu, L. Severe maternal stress exposure due to bereavement before, during and after pregnancy and risk of overweight and obesity in young adult men: a Danish National Cohort Study.

PLoS ONE 9 , e Jasarevic, E. The maternal vaginal microbiome partially mediates the effects of prenatal stress on offspring gut and hypothalamus. Mueller, N. Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity. Dominguez-Bello, M.

Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Marcobal, A. Human milk oligosaccharide consumption by intestinal microbiota.

Roger, L. Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life. Microbiology , — Tamburini, S. The microbiome in early life: implications for health outcomes. Hart, A. Modulation of human dendritic cell phenotype and function by probiotic bacteria.

Gut 53 , — The influence of early infant-feeding practices on the intestinal microbiome and body composition in infants. Insights 8 , 1—9 Bogen, D. The effect of breast-feeding with and without formula use on the risk of obesity at 4 years of age.

Koenig, J. Succession of microbial consortia in the developing infant gut microbiome. Forbes, J. Association of exposure to formula in the hospital and subsequent infant feeding practices with gut microbiota and risk of overweight in the first year of life.

JAMA Pediatr. Yan, J. The association between breastfeeding and childhood obesity: a meta-analysis.

BMC Public. Health 14 , Monteiro, C. Household availability of ultra-processed foods and obesity in nineteen European countries. Health Nutr. Martinez Steele, E. Ultra-processed foods and added sugars in the US diet: evidence from a nationally representative cross-sectional study.

BMJ Open 6 , e Hall, K. Did the food environment cause the obesity epidemic? Obesity 26 , 11—13 Sadeghirad, B. Uribe, R. The effects of TV unhealthy food brand placement on children. Its separate and joint effect with advertising. Appetite 91 , — Hicks, L. outpatient antibiotic prescribing, Stark, C.

Antibiotic and acid-suppression medications during early childhood are associated with obesity. Gut 68 , 62—69 Yassour, M. Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability.

Transl Med. Ajslev, T. Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics. Cox, L. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences.

Cell , — Candon, S. Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes. PLoS ONE 10 , e Gaskins, H.

Antibiotics as growth promotants: mode of action. Cho, I. Antibiotics in early life alter the murine colonic microbiome and adiposity. Ruiz, V. A single early-in-life macrolide course has lasting effects on murine microbial network topology and immunity. Hemmingsson, E. Early childhood obesity risk factors: socioeconomic adversity, family dysfunction, offspring distress, and junk food self-medication.

Farr, O. Posttraumatic stress disorder, alone or additively with early life adversity, is associated with obesity and cardiometabolic risk. Effects of childhood abuse on adult obesity: a systematic review and meta-analysis. Forster, G. Negative consequences of early-life adversity on substance use as mediated by corticotropin-releasing factor modulation of serotonin activity.

Whitesell, N. Childhood exposure to adversity and risk of substance-use disorder in two American Indian populations: the meditational role of early substance-use initiation. Drugs 70 , — Moffett, M. Maternal separation alters drug intake patterns in adulthood in rats.

Moussaoui, N. Chronic early-life stress in rat pups alters basal corticosterone, intestinal permeability, and fecal microbiota at weaning: influence of sex.

Isohookana, R. The impact of adverse childhood experiences on obesity and unhealthy weight control behaviors among adolescents. Psychiatry 71 , 17—24 Windle, M. A multivariate analysis of adverse childhood experiences and health behaviors and outcomes among college students.

Health 66 , — Campbell, J. Using path analysis to examine the relationship between sexual abuse in childhood and diabetes in adulthood in a sample of US adults. Van Niel, C.

Adverse events in children: predictors of adult physical and mental conditions. History of early life adversity is associated with increased food addiction and sex-specific alterations in reward network connectivity in obesity.

Martin, B. Sex-dependent metabolic, neuroendocrine, and cognitive responses to dietary energy restriction and excess. Endocrinology , — Inam, Q. Effects of sugar rich diet on brain serotonin, hyperphagia and anxiety in animal model of both genders.

Correlation of tryptophan metabolites with connectivity of extended central reward network in healthy subjects. PLoS ONE 13 , e Leigh, S. Hyperpalatability and the generation of obesity: roles of environment, stress exposure and individual difference. Food cravings, food intake, and weight status in a community-based sample.

Mozaffarian, D. Changes in diet and lifestyle and long-term weight gain in women and men. Current considerations regarding food addiction. Psychiatry Rep. Nunes-Neto, P. Food addiction: prevalence, psychopathological correlates and associations with quality of life in a large sample.

Wu, G. Linking long-term dietary patterns with gut microbial enterotypes. Science , — Xu, Z. Dietary effects on human gut microbiome diversity. English, L. Mechanisms of the portion size effect.

What is known where do we go here? Appetite 88 , 39—49 Kerr, M. Food and the consumer: could labelling be the answer? Lucan, S. Unhealthful food-and-beverage advertising in subway stations: targeted marketing, vulnerable groups, dietary intake, and poor health. Health 94 , — Coates, A.

Pediatrics , e Norman, J. Folkvord, F. The role of attentional bias in the effect of food advertising on actual food intake among children. Appetite 84 , — Deglaire, A. Associations between weight status and liking scores for sweet, salt and fat according to the gender in adults the Nutrinet-Sante study.

Geiker, N. Does stress influence sleep patterns, food intake, weight gain, abdominal obesity and weight loss interventions and vice versa?

Food cravings mediate the relationship between chronic stress and body mass index. Health Psychol. Chronic stress, drug use, and vulnerability to addiction. NY Acad. Stress, cortisol, and other appetite-related hormones: prospective prediction of 6-month changes in food cravings and weight.

Obesity 25 , — Dallman, M. Stress-induced obesity and the emotional nervous system. Christiansen, A. Ulrich-Lai, Y. Pleasurable behaviors reduce stress via brain reward pathways. Bharwani, A. Psychoneuroendocrinology 63 , — Depommier, C. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study.

Gheorghe, C. Focus on the essentials: tryptophan metabolism and the microbiome-gut-brain axis. Gut microbiome and modulation of CNS function. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis.

Wikoff, W. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Yano, J. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Kim, D. Serotonin: a mediator of the brain-gut connection.

Hood, S. Acute tryptophan depletion. Part I: rationale and methodology. Psychiatry 39 , — Pagoto, S. Acute tryptophan depletion and sweet food consumption by overweight adults. Roager, H. Microbial tryptophan catabolites in health and disease. Bender, D. Biochemistry of tryptophan in health and disease.

Schwarcz, R. Kynurenines in the mammalian brain: when physiology meets pathology. Marin, I. Microbiota alteration is associated with the development of stress-induced despair behavior.

Stavrum, A. Model of tryptophan metabolism, readily scalable using tissue-specific gene expression data.

Favennec, M. The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation. Obesity 23 , — Kennedy, P. Kynurenine pathway metabolism and the microbiota-gut-brain axis.

Neuropharmacology , — Chimerel, C. Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells. Cell Rep. Mangge, H.

Obesity-related dysregulation of the tryptophan-kynurenine metabolism: role of age and parameters of the metabolic syndrome. Obesity 22 , — Buckman, L. Obesity induced by a high-fat diet is associated with increased immune cell entry into the central nervous system. Teixeira, T.

Potential mechanisms for the emerging link between obesity and increased intestinal permeability. Sonnenburg, E. Diet-induced extinctions in the gut microbiota compound over generations. Rasoamanana, R.

Dietary fibers reduce food intake by satiation without conditioned taste aversion in mice. Tailford, L. Mucin glycan foraging in the human gut microbiome.

Shen, W. Ding, S. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS ONE 5 , e Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 , — Chang, M.

Breakdown of mucin as barrier to digestive enzymes in the ischemic rat small intestine. PLoS ONE 7 , e Hotamisligil, G. Inflammation and metabolic disorders.

Wang, Q. Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation. Larraufie, P. TLR ligands and butyrate increase Pyy expression through two distinct but inter-regulated pathways. Cell Microbiol. Palazzo, M. Activation of enteroendocrine cells via TLRs induces hormone, chemokine, and defensin secretion.

Kidd, M. de Lartigue, G. Vagal plasticity the key to obesity. Diet-induced obesity leads to the development of leptin resistance in vagal afferent neurons. Vagal afferent neurons in high fat diet-induced obesity; intestinal microflora, gut inflammation and cholecystokinin.

Qin, Y. An obesity-associated gut microbiome reprograms the intestinal epigenome and leads to altered colonic gene expression.

Genome Biol. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50 , — Peterli, R. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial.

JAMA , — Chang, S. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, JAMA Surg. Scholtz, S. Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding. Gut 63 , — Changes in taste perception and eating behavior after bariatric surgery-induced weight loss in women.

Obesity 22 , E13—E20 Sanmiguel, C. Gastroenterology , S Kanerva, N. Changes in total energy intake and macronutrient composition after bariatric surgery predict long-term weight outcome: findings from the Swedish Obese Subjects SOS study.

Konttinen, H. Psychological aspects of eating behavior as predictors of y weight changes after surgical and conventional treatment of severe obesity: results from the Swedish Obese Subjects intervention study. Makaronidis, J. Reported appetite, taste and smell changes following Roux-en-Y gastric bypass and sleeve gastrectomy: effect of gender, type 2 diabetes and relationship to post-operative weight loss.

Appetite , 93— Bariatric surgery-induced weight loss causes remission of food addiction in extreme obesity. Basso, N. First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis.

le Roux, C. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Faulconbridge, L. Changes in neural responsivity to highly palatable foods following Roux-en-Y gastric bypass, sleeve gastrectomy, or weight stability: an fMRI study.

Obesity 24 , — Li, J. Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut 60 , — Li, M. Symbiotic gut microbes modulate human metabolic phenotypes. The total score ranges between 0 and , with higher scores indicating increased food related inhibitory control.

Preliminary validation proposes a four-factor solution with the subscales Action Withdrawal AW, e. The subscale emotional eating of the German translation of the Dutch Eating Behaviour Questionnaire DEBQ, Van Strien et al. The original self-report questionnaire consists of 30 items. The subscale score ranges between 10 and 50 points.

Good psychometric properties of the German version of the scale have been demonstrated by Nagl and colleagues Nagl et al. The German version of the Weight Bias Internalization Scale WBIS, Hilbert et al. The WBIS consists of 11 items which are rated on a seven-point scale ranging from strongly disagree 1 to strongly agree 7.

The total score ranges between 11 and The German version showed good psychometric properties Hilbert et al. To measure self-efficacy, the General Self-Efficacy Scale SWE, Jerusalem and Schwarzer, was used.

The self-report questionnaire consists of 10 items, each of it answered on a four-point scale ranging from not at all true 1 to exactly true 4 , yielding a total score between 10 and 40 points. The SWE showed good psychometric properties in a representative German sample Hinz et al. All analyses were conducted with IBM SPSS statistics for windows Version and Microsoft Excel Version Descriptive analyses were conducted using percentages and frequencies for categorical variables, as well as means and standard deviations for continuous variables.

Chi-square distributions that compared categorical variables between groups FA vs. NFA were implemented as well as Bonferroni-adjusted independent t -tests to compare metrically scaled variables. Associations between metrically scaled variables were analysed using Pearson correlations.

The study was carried out in accordance with the Declaration of Helsinki. The Institutional Review Board of the Ruhr-University Bochum approved the study Nr.

All subjects were informed about the study and all provided written informed consent. Table 2 gives an overview about sociodemographic factors both of the total sample and the subsamples of individuals experiencing food addiction FA or not experiencing FA NFA.

No differences between the subsamples FA vs. NFA regarding gender, age, BMI, marital status and education could be found. Table 4 illustrates results from independent t-Tests between the subsamples FA vs. NFA on psychosocial measurements and psychopathology.

FA participants showed significantly higher FA symptom severity YFAS 2. Additionally, the GSI BSI was higher for FA compared to NFA participants, indicating higher psychological distress.

Moreover, FA participants scored less on three of four FRIS subscales AW, AC and RS , indicating impairments in behavioural inhibitory control and increased reward sensitivity.

The groups did not differ on the subscale DD, reflecting impulsive choices. Table 4. Psychopathology and weight- and addiction-related constructs FA vs. The main aim of the present study was to assess the prevalence of FA in a treatment-seeking sample of individuals with overweight or obesity and without comorbid BN or BED as previous studies did not control for these comorbid disorders.

Notably, the higher prevalence rates in female participants might also be explained by a general tendency of women to over-report health problems compared to men Boerma et al.

Our findings fit the assumption that the prevalence of FA is higher in individuals with overweight and obesity The lower prevalence rate in our study might therefore be due to the fact, that individuals suffering from BN or BED were excluded from participation.

FA severity was associated with increased BMI, which is in line with findings of previous studies Pedram et al. A variety of studies reports associations between FA and SUDs Davis and Carter, ; García-García et al.

In our study, AUD severity was not associated with FA. This might be because hazardous alcohol consumption was an exclusion criterion for participation, but the missing correlation could also be masked by the inverse relationship between AUD and BMI.

However, in line with previous studies, FA was associated with severity of depressive symptoms and psychological distress Gearhardt et al. Although participants meeting the diagnostic criteria for major depression and AUD were excluded from participation, our results underline the strong relationship between FA symptomatology and mood disorders, and enlighten the high level of distress in individuals experiencing FA, which together might contribute to weight gain Bourdier et al.

FA was linked to IUD severity. IUD is a behavioural addiction characterized by excessive internet usage and an impaired control over usage behaviour Young, Excessive internet usage is associated with unhealthy eating and sedentary behaviour and might subsequently aggravate FA symptomatology and contribute to weight gain Vandelanotte et al.

Moreover, FA was linked to emotional eating and WBI and both were significantly higher in FA compared to NFA participants. There seems to be a shift from positive reinforcement to negative reinforcement in individuals experiencing FA regarding the consumption of palatable food Parylak et al.

Given that palatable food can be both rewarding and stress reducing, food deprivation may lead to withdrawal i. In line with previous studies, self-efficacy was negatively correlated to FA symptom severity in our sample Burmeister et al.

Low self-efficacy and high WBI are linked to lower physical activity and WBI predicts reduced odds of achieving weight-loss in individuals with overweight and obesity Hübner et al. Therefore, the reported associations between FA, WBI and self-efficacy fits prior observations that individuals experiencing FA suffer from weight cycling Gearhardt et al.

It is assumed that the relationship between WBI and FA is moderated by emotional dysregulation, which should be further investigated Baldofski et al. Future studies might also consider assessing weight control or eating self-efficacy instead of global self-efficacy Linde et al.

FA was associated with an impulsive eating behaviour and deficits in food-related inhibitory control. FA participants significantly differed from NFA participants in food-related impulsive actions action withdrawal and cancelation , as well as reward sensitivity.

This indicates that individuals experiencing FA have more problems in resisting impulses towards disposable and rewarding food and might therefore need specific training elements to enhance weight loss Meule, a.

Delay discounting was associated with FA symptom severity, but the subgroup of FA participants did not significantly differ from NFA participants on this subscale. This might be due to the fact that delay discounting is generally increased in individuals with obesity Mole et al.

Interestingly, FA was not associated with the impulsivity personality trait. This is in contrast to prior studies indicating that FA, as well as other SUDs and EDs are associated with higher impulsivity traits Mobbs et al. Since BN, BES and AUD were exclusion criteria in our study, it might be possible, that overlapping symptoms with this disorders confounded prior results.

Based on our results, we hypothesize that not a global disposition towards impulsive behaviour, but rather a learning process that food is rewarding and disposable, may contribute to the impulsive eating behaviour in FA participants.

In our study, impulsivity personality trait, impulsive eating behaviour and food-related inhibitory control were measured using self-reporting questionnaires. Since self-reported and behavioural results regarding disinhibition of eating behaviour in individuals with obesity can differ, the results of our study should be further analysed using behavioural tasks Loeber et al.

Furthermore, potential moderating factors like restrained eating or current mood should be considered Loeber et al. A particular strength of our study is that we analysed FA in a sample of individuals with overweight and obesity who did not suffer from eating disorders, which was verified by questionnaire and structured interview two stage design.

However, when interpreting the findings of the present study a few limitations should be acknowledged. It can be assumed that the prevalence of FA would have been higher when including these participants, since FA is reported to be increased in individuals experiencing extreme obesity ca.

In addition, since AUD and major depression were exclusion criteria, the reported associations between FA, AUD severity and severity of depressive symptoms might be confounded.

Since the risk for FA increases in polyabusers, the exclusion of individuals suffering from hazardous alcohol consumption might subsequently cause a lower prevalence of FA in our study Tinghino et al.

Finally, a broad test battery, i. Still, our conclusions are based on results from self-reporting questionnaires and different results may be observed when using behavioural measurements as for example reported by Loeber et al. In addition, typical pre-test self-report biases are known, which might have further influenced our results Aiken and West, With a view to a potential inclusion of FA in the diagnostic catalogues, it would make sense to develop and use objective diagnostic assessment tools, like structured interviews Gearhardt and Hebebrand, ; Hebebrand and Gearhardt, The interpretation of our results is aggravated due to our cross-sectional study design, i.

It would subsequently be meaningful to verify the results in longitudinal studies, i. Summing up, our results support the view that, even when adjusting for BN and BED, a relevant subgroup of individuals with overweight and obesity experiences an addiction-like eating behaviour.

This subgroup differs from non-addictive eaters on several weight- and addiction-related factors, like emotional eating, WBI, and impulsivity. Moreover, individuals experiencing FA suffer from depressive symptoms, addictive disorders and psychological distress.

In sum, these impairments may contribute to weight gain. If so, our results underline that the lack of an officially approved FA diagnosis might currently cause an insufficient clinical care for individuals experiencing an addiction-like eating behaviour.

It might therefore be reasonable to investigate the effect of FA on weight loss when adjusting for eating disorders and to further implicate addiction-specific therapeutic elements in WLPs to enhance weight loss and prevent weight regain in this subgroup.

The datasets presented in this article are not readily available because data will be made available only on reasonable request. Requests to access the datasets should be directed to magdalena. pape rub. The studies involving human participants were reviewed and approved by The Institutional Review Board of the Ruhr-University Bochum Nr.

MP: conceptualisation, acquisition of data, formal analysis, interpretation of data, and writing — original draft.

SH: conceptualisation, writing- original draft, and study supervision. SS and CS: study design, acquisition of data, and review and editing. TF: acquisition of data and review and editing. JW: study design, study supervision, and review and editing.

SS-L: study design and conceptualisation, study supervision, and review and editing. All authors contributed to the article and approved the submitted version.

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers.

Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher. The authors acknowledge support by the Open Access Publication Fund of the University of Bamberg. We acknowledge Tanja Roth, Sophia Everding, and Hannah Birk for research assistance, as well as Hans Maximilian Henrich for language proofreading.

Aiken, L. Invalidity of true experiments: self-report pretest biases. doi: CrossRef Full Text Google Scholar.

Avena, N. PubMed Abstract CrossRef Full Text Google Scholar. Baldofski, S. Weight bias internalization, emotion dysregulation, and non-normative eating behaviors in prebariatric patients. Bari, A. Inhibition and impulsivity: Behavioral and neural basis of response control.

Beitscher-Campbell, H. Pilot clinical observations between food and drug seeking derived from fifty cases attending an eating disorder clinic. Blaine, B. Responses to weight loss treatment among obese individuals with and without BED: A matched-study meta-analysis.

Weight Disord. Boerma, T. A global assessment of the gender gap in self-reported health with survey data from 59 countries. BMC Public Health Bourdier, L. Are emotionally driven and addictive-like eating behaviors the missing links between psychological distress and greater body weight?

Appetite , — Burger, K. Frequent ice cream consumption is associated with reduced striatal response to receipt of an ice cream—based milkshake. Burmeister, J.

Food addiction in adults seeking weight loss treatment. Implications for psychosocial health and weight loss. Appetite 60, — Burrows, T. Food addiction and associations with mental health symptoms: a systematic review with meta-analysis. Food addiction, binge eating disorder, and obesity: is there a relationship?

Cassin, S. Ethical, stigma, and policy implications of food addiction: a scoping review. Nutrients Chalk, M. Obesity: addressing a multifactorial disease. Case Manager 15, 47— Chao, A. Effects of addictive-like eating behaviors on weight loss with behavioral obesity treatment.

Chu, D. An update on obesity: mental consequences and psychological interventions. Diabetes Metab. Churchill, S. Reflective and non-reflective antecedents of health-related behaviour: exploring the relative contributions of impulsivity and implicit self-control to the prediction of dietary behaviour.

Health Psychol. Clark, S. Validation of the Yale Food Addiction Scale among a weight-loss surgery population. Conigrave, K. The AUDIT questionnaire: choosing a cut-off score.

Alcohol use disorder identification test. Addiction 90, — Davis, C. The epidemiology and genetics of binge eating disorder BED. CNS Spectr. Compulsive overeating as an addiction disorder.

A review of theory and evidence. Appetite 53, 1—8. De Vries, S. Food addiction and bulimia nervosa: new data based on the Yale Food Addiction Scale 2.

Derogatis, L. Maruish Lawrence Erlbaum Associates Publishers , 1— Google Scholar. Dybek, I. The reliability and validity of the alcohol use disorders identification test AUDIT in a German general practice population sample. Alcohol 67, — Eichen, D. Appetite 67, 22— Fichter, M.

Fielding-Singh, P. Baseline psychosocial and demographic factors associated with study attrition and month weight gain in the DIETFITS trial.

Obesity 27, — García-García, I. Reward processing in obesity, substance addiction and non-substance addiction. Gearhardt, A. Preliminary validation of the Yale food addiction scale.

Appetite 52, — Development of the Yale Food Addiction Scale Version 2. An examination of food addiction in a racially diverse sample of obese patients with binge eating disorder in primary care settings.

Psychiatry 54, — An examination of the food addiction construct in obese patients with binge eating disorder. Neural correlates of food addiction.

Psychiatry 68, — Grosshans, M. Association of leptin with food cue—induced activation in human reward pathways. Psychiatry 69, — Hauck, C.

Facts 10, 12— Hebebrand, J. Herpertz, S. Prevalence of mental disorders in normal-weight and obese individuals with and without weight loss treatment in a German urban population.

Hilbert, A. Weight bias internalization scale: psychometric properties and population norms. PLoS One 9:e Eating Disorder Examination-Questionnaire: Deutschsprachige Übersetzung [Eating Disorder Examination-Questionnaire: German version]. Dgvt-Verlag: Tübingen, Germany.

Hinz, A. Bevölkerungsrepräsentative Normierung der Skala zur Allgemeinen Selbstwirksamkeitserwartung. Diagnostica 52, 26— Hofmann, W.

Impulse and self-control from a dual-systems perspective. Hübner, C. Influences of general self-efficacy and weight bias internalization on physical activity in bariatric surgery candidates. Jeffery, R. Long-term maintenance of weight loss: current status.

Jensen, M. New obesity guidelines: promise and potential. JAMA , 23— Jerusalem, M. SWE-Skala zur Allgemeinen Selbstwirksamkeitserwartung. Kroenke, K. The PHQ validity of a brief depression severity measure. Lent, M. Relationship of food addiction to weight loss and attrition during obesity treatment.

Obesity 22, 52— Linde, J. Binge eating disorder, weight control self-efficacy, and depression in overweight men and women. Loeber, S. Impairment of inhibitory control in response to food-associated cues and attentional bias of obese participants and normal-weight controls. Mood and restrained eating moderate food-associated response inhibition in obese individuals with binge eating disorder.

Is Obesity an Addiction?

Model of tryptophan metabolism, readily scalable using tissue-specific gene expression data. Favennec, M. The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation. Obesity 23 , — Kennedy, P.

Kynurenine pathway metabolism and the microbiota-gut-brain axis. Neuropharmacology , — Chimerel, C. Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells. Cell Rep. Mangge, H. Obesity-related dysregulation of the tryptophan-kynurenine metabolism: role of age and parameters of the metabolic syndrome.

Obesity 22 , — Buckman, L. Obesity induced by a high-fat diet is associated with increased immune cell entry into the central nervous system. Teixeira, T. Potential mechanisms for the emerging link between obesity and increased intestinal permeability.

Sonnenburg, E. Diet-induced extinctions in the gut microbiota compound over generations. Rasoamanana, R. Dietary fibers reduce food intake by satiation without conditioned taste aversion in mice. Tailford, L. Mucin glycan foraging in the human gut microbiome.

Shen, W. Ding, S. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS ONE 5 , e Metabolic endotoxemia initiates obesity and insulin resistance.

Diabetes 56 , — Chang, M. Breakdown of mucin as barrier to digestive enzymes in the ischemic rat small intestine. PLoS ONE 7 , e Hotamisligil, G. Inflammation and metabolic disorders. Wang, Q. Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation.

Larraufie, P. TLR ligands and butyrate increase Pyy expression through two distinct but inter-regulated pathways. Cell Microbiol. Palazzo, M. Activation of enteroendocrine cells via TLRs induces hormone, chemokine, and defensin secretion.

Kidd, M. de Lartigue, G. Vagal plasticity the key to obesity. Diet-induced obesity leads to the development of leptin resistance in vagal afferent neurons.

Vagal afferent neurons in high fat diet-induced obesity; intestinal microflora, gut inflammation and cholecystokinin. Qin, Y. An obesity-associated gut microbiome reprograms the intestinal epigenome and leads to altered colonic gene expression.

Genome Biol. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

Diabetologia 50 , — Peterli, R. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA , — Chang, S. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, JAMA Surg.

Scholtz, S. Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding. Gut 63 , — Changes in taste perception and eating behavior after bariatric surgery-induced weight loss in women.

Obesity 22 , E13—E20 Sanmiguel, C. Gastroenterology , S Kanerva, N. Changes in total energy intake and macronutrient composition after bariatric surgery predict long-term weight outcome: findings from the Swedish Obese Subjects SOS study. Konttinen, H. Psychological aspects of eating behavior as predictors of y weight changes after surgical and conventional treatment of severe obesity: results from the Swedish Obese Subjects intervention study.

Makaronidis, J. Reported appetite, taste and smell changes following Roux-en-Y gastric bypass and sleeve gastrectomy: effect of gender, type 2 diabetes and relationship to post-operative weight loss. Appetite , 93— Bariatric surgery-induced weight loss causes remission of food addiction in extreme obesity.

Basso, N. First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis.

le Roux, C. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Faulconbridge, L. Changes in neural responsivity to highly palatable foods following Roux-en-Y gastric bypass, sleeve gastrectomy, or weight stability: an fMRI study.

Obesity 24 , — Li, J. Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut 60 , — Li, M. Symbiotic gut microbes modulate human metabolic phenotypes. Arora, T. Roux-en-Y gastric bypass surgery induces early plasma metabolomic and lipidomic alterations in humans associated with diabetes remission.

Gralka, E. Metabolomic fingerprint of severe obesity is dynamically affected by bariatric surgery in a procedure-dependent manner. Ryan, K. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Coveleskie, K. The effect of the GLP-1 analogue exenatide on functional connectivity within an NTS-based network in women with and without obesity.

Braas, D. Dynamic changes in gut microbial derived indole and phenol products after bariatric surgery and its relationship to weight loss. Jacobs, J. Glutamate and hedonic eating: role of the brain-gut-microbiome axis on changes on hedonic eating after bariatric surgery.

Gastroenterology , s Lee, C. Changes in gut microbiome after bariatric surgery versus medical weight loss in a pilot randomized trial. Guo, Y. Modulation of the gut microbiome: a systematic review of the effect of bariatric surgery. Luijten, J. The importance of the microbiome in bariatric surgery: a systematic review.

Monte, S. Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus.

Surgery , — Iannelli, A. Inflammation, insulin resistance, lipid disturbances, anthropometrics, and metabolic syndrome in morbidly obese patients: a case control study comparing laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy. Body composition, anthropometrics, energy expenditure, systemic inflammation, in premenopausal women 1 year after laparoscopic Roux-en-Y gastric bypass.

Yadav, R. Effect of Roux-en-Y bariatric surgery on lipoproteins, insulin resistance, and systemic and vascular inflammation in obesity and diabetes. Peng, Y. Roux-en-Y gastric bypass improves glucose homeostasis, reduces oxidative stress and inflammation in livers of obese rats and in Kupffer cells via an AMPK-dependent pathway.

Surgery , 59—67 Lindegaard, K. Effects of Roux-en-Y gastric bypass on fasting and postprandial inflammation-related parameters in obese subjects with normal glucose tolerance and in obese subjects with type 2 diabetes.

van de Sande-Lee, S. Partial reversibility of hypothalamic dysfunction and changes in brain activity after body mass reduction in obese subjects. Diabetes 60 , — Blackburn, A.

The gut in the brain: the effects of bariatric surgery on alcohol consumption. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Kootte, R. Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition.

Dailey, F. The dirty aspects of fecal microbiota transplantation: a review of its adverse effects and complications. Longo, V. Fasting, circadian rhythms, and time-restricted feeding in healthy lifespan.

Melkani, G. Time-restricted feeding for prevention and treatment of cardiometabolic disorders. Di Francesco, A. A time to fast. Kohsaka, A. High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Hatori, M. Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet.

Gill, S. A smartphone app reveals erratic diurnal eating patterns in humans that can be modulated for health benefits. Thaiss, C. Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis.

Racz, B. Links between the circadian rhythm, obesity and the microbiome. Ara, R. What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care?

A systematic review. Health Technol. Shin, J. Diabetes Metab. Hainer, V. Tolerability and safety of the new anti-obesity medications. Billes, S. Wellman, P. Synergistic interactions between fenfluramine and phentermine.

Lam, D. Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors. McElroy, S. Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study.

Psychiatry 61 , — Anderberg, R. Glucagon-like peptide 1 and its analogs act in the dorsal raphe and modulate central serotonin to reduce appetite and body weight.

Diabetes 66 , — Wang, Z. Gut microbiome differences between metformin- and liraglutide-treated T2DM subjects. Foster, D. Multidisciplinary team-based obesity treatment in patients with diabetes: current practices and the state of the science.

Diabetes Spectr. Cooper, Z. A new cognitive behavioural approach to the treatment of obesity. Klumpp, H. Neural response during attentional control and emotion processing predicts improvement after cognitive behavioral therapy in generalized social anxiety disorder.

Jensen, K. Cognitive behavioral therapy increases pain-evoked activation of the prefrontal cortex in patients with fibromyalgia.

Pain , — Seminowicz, D. Cognitive-behavioral therapy increases prefrontal cortex gray matter in patients with chronic pain. Brunoni, A. Cognitive control therapy and transcranial direct current stimulation for depression: a randomized, double-blinded, controlled trial.

Clay, S. A review of addiction. Labus, J. Randomised clinical trial: symptoms of the irritable bowel syndrome are improved by a psycho-education group intervention. An, H. Cognitive-behavioral therapy. Sawamoto, R. Predictors of successful long-term weight loss maintenance: a two-year follow-up.

Mindfulness-based interventions for obesity-related eating behaviours: a literature review. Lappalainen, R. The effectiveness and applicability of different lifestyle interventions for enhancing wellbeing: the study design for a randomized controlled trial for persons with metabolic syndrome risk factors and psychological distress.

BMC Public Health 14 , Talking microbes: when gut bacteria interact with diet and host organs. Food Res. Download references. We acknowledge C. Sanmiguel for her contributions in making editorial suggestions to the gut-directed therapies section of this review and C.

Liu for invaluable editorial services. has been supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases DK, DK and DK Oppenheimer Family Center for Neurobiology of Stress and Resilience, Ingestive Behavior and Obesity Program, University of California Los Angeles, Los Angeles, CA, USA.

David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. Vatche and Tamar Manoukian Division of Digestive Diseases, University of California Los Angeles, Los Angeles, CA, USA.

Ahmanson-Lovelace Brain Mapping Center at University of California Los Angeles, University of California Los Angeles, Los Angeles, CA, USA. You can also search for this author in PubMed Google Scholar. Correspondence to Emeran A.

serves on the scientific advisory boards of Amare, APC Microbiome Ireland, Axial Biotherapeutics, Bloom Science, Danone, Mahana Therapeutics, Pendulum and Viome. and V. declare no competing interests. Brown, E. Jerlhag, P.

Kenny and L. Leggio for their contribution to the peer review of this work. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

An interdisciplinary field of study that focuses on complex interactions within multiple biological systems, rather than focusing on individual mechanisms. The extensive network of neurons in the extended reward network that depend on dopamine as the primary neurotransmitter for reward-related processing.

Processes associated with reward sensitivity, motivation, interoceptive awareness, stress reactivity and self-control. Region of the basal ganglia and a key hub for the core reward system, responsible for many dopaminergic processes, especially those related to pleasure, motivation and aversion.

Key region of the midbrain that houses the dopaminergic cell bodies that project to all regions of the core and extended reward network. The brain network responsible for monitoring the homeostatic state of the body to make adaptive adjustments to real or expected disturbances in homeostasis through the autonomic nervous system and behavioural responses.

The extensive communication network between the cortex, which houses the extended reward network including the frontal cortex and insula and the striatum, which houses the core reward network nucleus accumbens, basal ganglia.

Dietary fibre or other substrates that can only be digested by commensal gut microorganisms, thereby promoting gut microbiota diversity and health. Behaviours used to cope with stressful situations to alleviate the stress or symptoms, but are not necessarily healthy and do not address the core cause of the stress.

Stress originating from the environment that is sufficient to cause dysregulation of homeostatic responses and physical or psychological symptoms.

The most widely used scale for perceived stress is the Perceived Stress Scale. Reprints and permissions. Brain—gut—microbiome interactions in obesity and food addiction.

Nat Rev Gastroenterol Hepatol 17 , — Download citation. Accepted : 24 June Published : 27 August Issue Date : November Anyone you share the following link with will be able to read this content:. Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative.

Applied Microbiology and Biotechnology Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Skip to main content Thank you for visiting nature. Subjects Gastrointestinal models Obesity. Abstract Normal eating behaviour is coordinated by the tightly regulated balance between intestinal and extra-intestinal homeostatic and hedonic mechanisms. Key points Food addiction refers to maladaptive ingestive behaviours resulting from a shift from primarily homeostatic to hedonic regulatory mechanisms of food intake; this shift reflects alterations at all levels of the brain—gut—microbiome BGM axis.

Access through your institution. Buy or subscribe. Change institution. Learn more. Google Scholar Mancini, M. PubMed PubMed Central Google Scholar Zhang, Y. CAS PubMed PubMed Central Google Scholar Heymsfield, S. CAS PubMed Google Scholar Osadchiy, V.

CAS PubMed Google Scholar Mayer, E. CAS PubMed Google Scholar Keita, A. CAS PubMed Google Scholar Yu, M. CAS PubMed Google Scholar Moreira, C.

CAS PubMed PubMed Central Google Scholar Houlden, A. CAS PubMed PubMed Central Google Scholar Sovran, B.

PubMed PubMed Central Google Scholar Barrett, E. CAS PubMed Google Scholar Shishov, V. CAS PubMed Google Scholar Asano, Y. CAS PubMed Google Scholar Maslowski, K. CAS PubMed PubMed Central Google Scholar Dalile, B.

PubMed Google Scholar McLoughlin, R. CAS PubMed Google Scholar Byrne, C. CAS PubMed PubMed Central Google Scholar Lal, S. CAS PubMed Google Scholar Diaz Heijtz, R. PubMed Google Scholar Bliss, E. PubMed PubMed Central Google Scholar Torres-Fuentes, C.

PubMed Google Scholar Ochoa-Reparaz, J. PubMed PubMed Central Google Scholar Buhmann, H. CAS PubMed Google Scholar Myers, M. CAS PubMed PubMed Central Google Scholar Guyenet, S. CAS PubMed PubMed Central Google Scholar Rossi, M.

CAS PubMed Google Scholar Volkow, N. CAS PubMed Google Scholar Lindgren, E. CAS Google Scholar Gearhardt, A. PubMed Google Scholar Gearhardt, A. PubMed PubMed Central Google Scholar Schulte, E. PubMed Google Scholar Schulte, E.

PubMed Google Scholar Randolph, T. CAS PubMed Google Scholar Meule, A. PubMed PubMed Central Google Scholar Corsica, J. PubMed Google Scholar Hone-Blanchet, A. CAS PubMed Google Scholar Gearhardt, A. PubMed Google Scholar American Psychiatric Association. PubMed Google Scholar Penzenstadler, L.

CAS PubMed PubMed Central Google Scholar Burrows, T. PubMed PubMed Central Google Scholar Chen, M. PubMed Google Scholar Kalon, E.

CAS PubMed PubMed Central Google Scholar DiLeone, R. CAS PubMed PubMed Central Google Scholar Rogers, P. CAS PubMed Google Scholar Ouellette, A. PubMed Google Scholar Davis, C. PubMed Google Scholar Meule, A. PubMed PubMed Central Google Scholar Avena, N. CAS PubMed Google Scholar Ziauddeen, H.

CAS PubMed Google Scholar Muller, A. PubMed Google Scholar Sevincer, G. PubMed PubMed Central Google Scholar Gearhardt, A. PubMed PubMed Central Google Scholar Nakazato, M. CAS PubMed Google Scholar Wren, A. CAS PubMed Google Scholar Jiang, H.

CAS PubMed Google Scholar Shah, M. CAS PubMed PubMed Central Google Scholar Karra, E. CAS PubMed Google Scholar Tolhurst, G. CAS PubMed PubMed Central Google Scholar Cani, P. CAS PubMed Google Scholar Parnell, J.

CAS PubMed Google Scholar Rodin, J. CAS PubMed Google Scholar Jiao, N. CAS PubMed Google Scholar Perry, R. CAS PubMed PubMed Central Google Scholar Fang, S.

CAS PubMed PubMed Central Google Scholar Pathak, P. CAS PubMed Google Scholar Vrieze, A. CAS PubMed Google Scholar Leitao-Goncalves, R. PubMed PubMed Central Google Scholar Ribeiro, C. CAS PubMed Google Scholar Storelli, G. CAS PubMed Google Scholar Kahathuduwa, C.

PubMed Google Scholar Berthoud, H. CAS PubMed PubMed Central Google Scholar Simon, J. PubMed Central Google Scholar Abizaid, A. CAS PubMed Google Scholar Gao, Q. CAS PubMed Google Scholar Berthoud, H. PubMed Google Scholar Harding, I. CAS Google Scholar Gupta, A. PubMed PubMed Central Google Scholar Gupta, A.

CAS Google Scholar Kenny, P. CAS PubMed PubMed Central Google Scholar Volkow, N. CAS PubMed Google Scholar Bartholdy, S. PubMed Google Scholar Steward, T. PubMed Google Scholar Stice, E. CAS PubMed PubMed Central Google Scholar Olivo, G.

PubMed PubMed Central Google Scholar Morrow, J. PubMed PubMed Central Google Scholar Garcia-Garcia, I. PubMed Google Scholar Volkow, N. CAS PubMed Google Scholar Wijngaarden, M. CAS PubMed Google Scholar Seeley, W. CAS PubMed PubMed Central Google Scholar Menon, V.

PubMed PubMed Central Google Scholar Zald, D. PubMed Google Scholar Kilpatrick, L. Programme withdrawal rate was operationalised by either official written notice of termination or a break-off of weekly measurements and documentation of body weight during the respective programme year.

For an overview of all score ranges and its meanings, see Table 1 and its notes. Variables analysed of the total sample and in comparison of the sub-samples with and without food addiction FA.

Statistical analyses were performed with Statistical Package for Social Science Software SPSS, IBM SPSS Statistics versions 25 and 26 [ 35 ].

t tests examined the differences between the sub-samples with and without FA in metric variables binge eating score, emotional eating score, the five FEV dimensions of eating behaviour, BMI, age, age at onset of obesity, stress level, degree of social support, weight loss during the programme after normal distribution has been tested graphically using Q-Q plots.

χ 2 tests examined differences in categorical variables prevalence of night eating, problematic consumption of the three food categories, sex, prevalence of other substance use, programme withdrawal rate.

To counteract alpha error cumulation, p values were adjusted using Bonferroni correction. In addition, multiple linear regression analysis tested possible determinants of FA. To further differentiate FA from binge eating, in a second step, the collective was divided into two new subgroups patients with exclusively FA without binge eating vs.

patients with exclusively binge eating without FA and these were compared as described above. Tables and figures were created in the spreadsheet Microsoft Excel version Table 1 shows the mean values of all analysed variables, including the differentiation in patients with and without FA, as well as the results of the inferential statistics.

No significant differences were found for sex, age, and BMI. Disinhibition, cognitive restraint, rigid and flexible control showed no significant differences. A multiple linear regression analysis was conducted with the variables disinhibition, hunger, cognitive control, age, and BMI.

The R 2 for the overall model was 0. These findings are demonstrated in Figure 1. Figure 2 illustrates the overlap between FA and binge eating and night eating, respectively.

The descriptive and analytical statistical key figures can be seen in online supplementary Table S2 for all online suppl. Comparison of patients with and without food addiction FA with regard to night eating a , emotional eating b , and binge eating c. a , b Overlap of food addiction FA and night eating NE and binge eating behaviour BE , respectively, in a patient population with morbid obesity.

Patients with FA descriptively consumed more foods rich in both carbohydrates and fat than patients without FA, although this was not statistically significant and had a small effect size. There were no differences respective of foods containing carbohydrates or fat alone.

The differences between the sub-samples with and without FA concerning all three food categories are illustrated in Figure 3. Comparison of patients with and without food addiction FA with regard to problematic food categories.

Stress level, social support, age at onset of obesity, BMI reduction during the weight loss programme, programme withdrawal rate, and prevalence of other substance use did not differ significantly between the two sub-samples.

No substances other than alcohol and smoking were reported. One quarter of the sample met the YFAS 2. This is consistent with other studies involving patients with pronounced obesity [ 11, 19 ].

The high prevalence among this sample of subjects with morbid obesity in contrast to lower prevalences in samples of healthy subjects indicates a considerable relevance of FA for the phenotype of some cases of obesity, but not all.

However, three-quarters of the obesity cases in this sample remain not associated with FA. In conclusion, for the majority of obesity cases, FA can apparently not serve as an aetiologic construct [ 36 ].

No statistically significant sex differences were observed between patients with and without FA, though descriptively, men had a higher prevalence than women. This is unexpected as it is not in line with most previous studies, which concordantly found women exhibiting a higher prevalence of FA than men [ 14, 17, 21, 22, 26 ] or no sex difference at all [ 4 ].

However, the majority of these studies were conducted with normal-weight populations. A single study of individuals with obesity was found; it showed a descriptively higher prevalence in men [ 37 ].

According to previous studies on populations with both normal weight and obesity, it would have been expected that the group with FA would show a lower age [ 5, 22, 37 ]. However, our study results do not support this hypothesis, as the descriptive differences were not significant and had small effect size.

The sample exhibited a mean BMI of No significant differences in BMI were observed between the sub-samples with and without FA, endorsing previous studies conducted in populations with obesity [ 23, 39, 40 ]. The lack of difference can be explained by the selection of the sample: all patients were participants of a weight reduction programme and were accordingly affected by pronounced obesity.

It is important to note that the questionnaire data used is not suitable for diagnosing a substance use disorder SUD according to DSM criteria. The prevalence of SUD according to DMS criteria is significantly lower in comparable populations of patients with morbid obesity 0.

The current study observed significantly more distinct feelings of hunger, with a large effect size, among patients with FA in contrast to those without, supporting previous studies in however normal-weight populations [ 14, 21 ].

Moreover, hunger and disinhibition proved to be significant predictors for FA. In samples with obesity, previous studies found correspondingly higher levels of impulsivity [ 23, 40 ].

On the one hand, this is at odds with another study on a sample with obesity, which found an association between binge eating and cognitive restraint [ 42 ].

On the other hand, previous studies on normal-weight populations have found the same lack of effect [ 21, 43 ]. High grades of disinhibition and hunger as decisive elements of impulsivity [ 44 ] are suggestive of dysfunctional behavioural regulation mechanisms.

Patients with FA seem to be more susceptible to disruptions in their planned eating, whether from external stimuli or internal, such as perceived hunger. This might contribute essentially to the binge eating behaviour seen in FA.

As previously stated, impulsivity is associated with binge eating disorder [ 45 ]. Previous studies have observed a relationship between low distress tolerance and both disinhibition and emotional eating [ 46 ]. In combination with the present findings, this suggests that dysfunctional emotional coping mechanisms associated with low distress tolerance could be a mediator between FA and disinhibition and hunger, respectively.

Patients with FA exhibited significantly higher emotional eating scores than patients without FA, with medium effect size, in line with previous studies on populations with obesity [ 27, 47 ]. These findings suggest that unpleasant feelings, such as fear, anger, sorrow, loneliness, sadness, and helplessness, can trigger uncontrolled excessive intake of food, as a means to dampen unpleasant emotional states.

Given that not all individuals use food to regulate their emotions, the prerequisite for such behaviour might be disturbed emotional coping mechanisms.

As disturbances in emotional coping can obviously contribute decisively to the development of addictive-like eating behaviour, FA appears to hold features of behavioural addiction.

The study at hand revealed significantly higher scores for binge eating behaviour in patients with FA in contrast to those without FA, with a large effect, in accordance with many previous studies on patients with obesity [ 23, 27, 48, 49 ]. Consequently, the uncontrolled consumption of excessively high amounts of food in a short time might be a decisive characteristic of not only binge eating disorder but of FA as well.

This is also confirmed by our data: significant differences between the subgroups with and without FA emotional eating, night eating, hunger are not confirmed in the comparison of FA and binge eating.

Accordingly, these variables must not be interpreted as characteristics of FA alone but characterise binge eating as well. Despite this, binge eating and FA cannot be regarded the same as is shown by the wide range of the binge eating score in the sub-sample with FA.

There were as well some patients fulfilling the FA criteria while exhibiting very low binge eating scores. This is in line with previous research concluding that BED and FA might be considered as distinct clinical phenomena [ 15 ].

Regarding the lack of effect when comparing FA and binge eating, the relatively small sample size and composition of the collective in this study should also be considered.

Significantly higher scores of binge eating behaviour in patients with FA lead to the hypothesis that FA might be characterised by eating to excess in a short period of time rather than perpetual food intake, so called grazing [ 15 ]. The high levels of disinhibition and hunger as decisive elements of impulsivity [ 44 ] may contribute significantly to the development of binge eating episodes.

It would be of crucial interest to differentiate the manner of binges in FA and binge eating disorder [ 14 ]. This merits scrutiny in future research. The sub-sample with FA exhibited a significantly higher prevalence of night eating than the sub-sample without FA, supporting previous studies on populations with obesity [ 47, 48 ], albeit with a small effect.

Consequently, it can be postulated that FA might be associated with difficulties in the maintenance of a circadian eating rhythm. As previous studies, however in normal-weight populations, suggested [ 17, 51 ], patients with FA were assumed to have significantly more problems with foods containing both carbohydrates and fat than patients without FA.

However, this effect was only observed descriptively, without statistical significance, and with small effect size. The lack of a relevant difference in our study could be related to the small size of our sample and its composition.

The aforementioned association of addictive eating behaviour and energy-dense food, as e. Foods containing only carbohydrates or fat showed no relevant differences.

These findings are consistent with studies on normal-weight individuals , which stated no association between FA and foods containing only carbohydrates [ 20 ]. Generalisability of the findings is limited due to the small number of subjects in relation to the large number of variables tested.

The results should be reviewed in future studies. Concerning binge eating this study is limited as the available data does not allow a full diagnosis of a clinically approved disorder according to DSM criteria but merely indicate binge eating behaviour.

The results are also limited with regard to emotional eating, as no validated construct was available to capture emotional eating. Instead, five questions from two questionnaires were combined into the emotional eating score, so that the two questionnaires may be confounded.

Future research should verify the results with validated tools. For this reason, the distinction between the food categories might be inaccurate, which could be relevant regarding the lack of significance of our results and should be further investigated in future studies.

Moreover, it would be of interest to examine in which context the problematic foods are consumed in the context of a meal, a snack, a binge eating episode , which was not captured by the present study. The questionnaire-based trait FA can be considered as a sub-phenotype of obesity, occurring in approximately one-quarter of obesity cases.

Dysfunctional emotional coping mechanisms associated with low distress tolerance were found to be significantly related to FA and should be suggested as therapeutic targets. Behavioural interventions should include a bio-psycho-social model [ 52 ] and address social and cultural aspects that may promote pathological eating behaviour media, beauty ideals, affiliation, exclusion.

In addition, binge eating episodes were found to be characteristic for FA. The results point to the already stated overlap between FA and binge eating disorder. However, the existence of FA as a distinct entity phenomenon should not be excluded, as not all patients with FA exhibit binges.

The same applies to the question of a substance-related or behavioural component of FA. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation institutional and national and with the Helsinki Declaration of and its later amendments.

Written informed consent was obtained from participants prior to the study. Pia Schankweiler played the leading role in analysing the data.

Pia Schankweiler drafted the manuscript. CrossRef Full Text Google Scholar. Avena, N. PubMed Abstract CrossRef Full Text Google Scholar. Baldofski, S. Weight bias internalization, emotion dysregulation, and non-normative eating behaviors in prebariatric patients.

Bari, A. Inhibition and impulsivity: Behavioral and neural basis of response control. Beitscher-Campbell, H. Pilot clinical observations between food and drug seeking derived from fifty cases attending an eating disorder clinic.

Blaine, B. Responses to weight loss treatment among obese individuals with and without BED: A matched-study meta-analysis. Weight Disord. Boerma, T. A global assessment of the gender gap in self-reported health with survey data from 59 countries.

BMC Public Health Bourdier, L. Are emotionally driven and addictive-like eating behaviors the missing links between psychological distress and greater body weight?

Appetite , — Burger, K. Frequent ice cream consumption is associated with reduced striatal response to receipt of an ice cream—based milkshake. Burmeister, J. Food addiction in adults seeking weight loss treatment. Implications for psychosocial health and weight loss.

Appetite 60, — Burrows, T. Food addiction and associations with mental health symptoms: a systematic review with meta-analysis. Food addiction, binge eating disorder, and obesity: is there a relationship?

Cassin, S. Ethical, stigma, and policy implications of food addiction: a scoping review. Nutrients Chalk, M. Obesity: addressing a multifactorial disease. Case Manager 15, 47— Chao, A. Effects of addictive-like eating behaviors on weight loss with behavioral obesity treatment.

Chu, D. An update on obesity: mental consequences and psychological interventions. Diabetes Metab. Churchill, S. Reflective and non-reflective antecedents of health-related behaviour: exploring the relative contributions of impulsivity and implicit self-control to the prediction of dietary behaviour.

Health Psychol. Clark, S. Validation of the Yale Food Addiction Scale among a weight-loss surgery population. Conigrave, K. The AUDIT questionnaire: choosing a cut-off score. Alcohol use disorder identification test. Addiction 90, — Davis, C. The epidemiology and genetics of binge eating disorder BED.

CNS Spectr. Compulsive overeating as an addiction disorder. A review of theory and evidence. Appetite 53, 1—8. De Vries, S. Food addiction and bulimia nervosa: new data based on the Yale Food Addiction Scale 2. Derogatis, L.

Maruish Lawrence Erlbaum Associates Publishers , 1— Google Scholar. Dybek, I. The reliability and validity of the alcohol use disorders identification test AUDIT in a German general practice population sample. Alcohol 67, — Eichen, D. Appetite 67, 22— Fichter, M.

Fielding-Singh, P. Baseline psychosocial and demographic factors associated with study attrition and month weight gain in the DIETFITS trial. Obesity 27, — García-García, I.

Reward processing in obesity, substance addiction and non-substance addiction. Gearhardt, A. Preliminary validation of the Yale food addiction scale. Appetite 52, — Development of the Yale Food Addiction Scale Version 2. An examination of food addiction in a racially diverse sample of obese patients with binge eating disorder in primary care settings.

Psychiatry 54, — An examination of the food addiction construct in obese patients with binge eating disorder. Neural correlates of food addiction. Psychiatry 68, — Grosshans, M. Association of leptin with food cue—induced activation in human reward pathways.

Psychiatry 69, — Hauck, C. Facts 10, 12— Hebebrand, J. Herpertz, S. Prevalence of mental disorders in normal-weight and obese individuals with and without weight loss treatment in a German urban population.

Hilbert, A. Weight bias internalization scale: psychometric properties and population norms. PLoS One 9:e Eating Disorder Examination-Questionnaire: Deutschsprachige Übersetzung [Eating Disorder Examination-Questionnaire: German version].

Dgvt-Verlag: Tübingen, Germany. Hinz, A. Bevölkerungsrepräsentative Normierung der Skala zur Allgemeinen Selbstwirksamkeitserwartung. Diagnostica 52, 26— Hofmann, W. Impulse and self-control from a dual-systems perspective. Hübner, C.

Influences of general self-efficacy and weight bias internalization on physical activity in bariatric surgery candidates. Jeffery, R. Long-term maintenance of weight loss: current status. Jensen, M. New obesity guidelines: promise and potential. JAMA , 23— Jerusalem, M. SWE-Skala zur Allgemeinen Selbstwirksamkeitserwartung.

Kroenke, K. The PHQ validity of a brief depression severity measure. Lent, M. Relationship of food addiction to weight loss and attrition during obesity treatment.

Obesity 22, 52— Linde, J. Binge eating disorder, weight control self-efficacy, and depression in overweight men and women. Loeber, S. Impairment of inhibitory control in response to food-associated cues and attentional bias of obese participants and normal-weight controls. Mood and restrained eating moderate food-associated response inhibition in obese individuals with binge eating disorder.

Psychiatry Res. Löwe, B. Gesundheitsfragebogen für Patienten PHQ-D. Komplettversion und Kurzform. Karlsruhe: Pfizer GmbH. Marmet, S. Unique versus shared associations between self-reported behavioral addictions and substance use disorders and mental health problems: a commonality analysis in a large sample of young Swiss men.

Meule, A. Focus: addiction: back by popular demand: a narrative review on the history of food addiction research. Yale J.

PubMed Abstract Google Scholar. Verlangen nach Süßem: Eine Evaluation der Suchtperspektive auf Zucker- und Süßstoffkonsum. A critical examination of the practical implications derived from the food addiction concept. Hebebrand and B. Herpertz-Dahlmann Amsterdam: Elsevier , 99— Food addiction in overweight and obese adolescents seeking weight-loss treatment.

German version of the Yale food addiction scale 2. Appetite , 54— Psychometrische Evaluation der deutschen Barratt Impulsiveness Scale—Kurzversion BIS Diagnostica 57, — Food addiction and bulimia nervosa. Minhas, M. Food addiction in a large community sample of Canadian adults: prevalence and relationship with obesity, body composition, quality of life and impulsivity.

Addiction doi: Mobbs, O. Obesity and the four facets of impulsivity. Patient Educ. Mole, T. Impulsivity in disorders of food and drug misuse.

Key points Antibiotics Obesity and food addiction early Obeaity dysbiosis and the damage anr. Ulrich-Lai, Y. USA— Obesity, it seems, is not caused by a lack of willpower. Made a searching and fearless moral inventory of ourselves.
By Addictiin J. Would vood rat risk dying just to Obesity and food addiction its desire Dood chocolate? I recently found out. In my Low glycemic breakfast, we gave rats unlimited access to their standard fare as well as to a mini cafeteria full of appetizing, high-calorie foods: sausage, cheesecake, chocolate. The rats decreased their intake of the healthy but bland items and switched to eating the cafeteria food almost exclusively. They gained weight. Obesity and food addiction

Author: Faugul

2 thoughts on “Obesity and food addiction

Leave a comment

Yours email will be published. Important fields a marked *

Design by ThemesDNA.com